JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares (ZJYL) — Analysis Summary
JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares (ZJYL) has a market cap of $173.11M with year-over-year revenue growth of -12.0%. Net margin stands at 5.8%. The stock trades at a P/E ratio of 145.3.
Key Takeaways
- Revenue changed -12.0% year-over-year
- Net margin of 5.8%
- P/E ratio of 145.3
Compared with its sector, ZJYL posted revenue growth of -12.0% and trades at a P/E of 145.3.
JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares (ZJYL)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Debt/EBITDA at 22.1x — highly leveraged, potential refinancing risk
The latest filing shows negative free cash flow.
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
Employees
273
Exchange
XNAS
Systematic competitive advantage assessment based on 3yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.